Page 2 - Best Non-Hodgkin's lymphoma doctors: TOP 73 doctors

Chief Physician of Oncology/Hematology at Klinikum Solingen – Dr. Fox leads a certified interdisciplinary cancer center.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics with a focus on molecular diagnostics
• Active in molecular biology research for innovative treatments
• Member of German Society of Oncology and American Association for Cancer Research

Prof. Elke Jaeger is a top German oncologist specializing in Non-Hodgkin's lymphoma, recognized by Focus rating.

• 41 years of experience of experience in oncology and hematology
• Head of Oncology and Hematology at Nordwest Clinic
• Specializes in sarcoma and complex lymphoma cases
• Recognized as one of Germany's best oncologists

A senior bone marrow transplantation specialist for Non-Hodgkin's lymphoma, Dr. Shapira is trained at one of Israel's leading centers.

• Over 36 years of experience of experience in hematology
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in the Bone Marrow Transplantation department
• Focuses on this complex treatment approach

36 years of experience at Memorial Sloan Kettering Cancer Center – Dr. Joffe specializes in lymphoma and CLL treatment at Sourasky Medical Center.

• Advanced subspecialty training in lymphomas and CLL
• Managed clinical studies in new drugs and immunotherapy
• Member of rare lymphoma treatment physician groups
• Senior doctor in Hematology and Bone Marrow Transplantation

With 34 years of experience focused on oncohematology, Dr. Aviv brings deep expertise in treating Non-Hodgkin's lymphoma at Ichilov Clinic.

• Specializes in blood cancers and complex hematologic conditions
• Works at Sourasky Medical Center – a leading oncology hospital
• Dedicated to personalized treatment approaches for each patient

Dr. Ayhan Gulsan specializes in Non-Hodgkin's lymphoma, with extensive training in stem cell transplantation at prestigious institutions like Duke University and Fred Hutchinson Cancer Research Center.

• Over 25 years of experience of experience in hematology and stem cell transplantation
• Founder and manager of Gazi University's Adult Stem Cell Transplant Unit
• Member of the Turkish Hematology Association
• Published numerous research papers on hematopoietic stem cell transplantation

Dr. Kodchanut is a hematologist with specialized training in Non-Hodgkin's lymphoma, working as a pioneer hematologist at Huahin Hospital.

• Graduated with honors from Naresuan University
• Completed hematology fellowship at Thammasat University
• Member of the Pharmacy and Therapeutics Committee
• Co-authored research on cancer-associated venous thromboembolism

Dr. Dror Levin directs the children's hematology oncology department at Sourasky Medical Center – a leading expert in pediatric blood disorders.

• Specializes in treating bone and soft tissue cancers (sarcomas) in children
• Board-certified in pediatric hematology and oncology
• Trained at Rizzoli Orthopaedic Institute – a world leader in bone oncology
• Member of the Israeli Society of Pediatric Hematology-Oncology
• Coordinates treatment programs for clotting disorders in children

Dr. Yair has made significant contributions to hematology, particularly in chronic lymphocytic leukemia, with numerous awards and published research.

• Recipient of multiple prestigious awards, including the Young Investigator Research Prize and Klitzberg Oncology Award
• Member of both the Israeli and American Hematology Associations
• Extensive training in hematology at Tel Aviv Medical Center
• Published researcher with grants from the Israeli Science Foundation and others

Univ. Prof. Dr. Wolfgang Köstler is a leading expert in personalized cancer medicine, specializing in breast cancer and gynecologic malignancies.

• Over 22 years of experience of experience in medical oncology and internal medicine
• Specializes in targeted therapies and individualized cancer treatment
• Associate Professor at the Medical University of Vienna
• Deputy Head of the Clinical Division of Oncology
• Active in translational cancer research and biomarker development

Professor Drach leads the Multiple Myeloma and Malignant Lymphoma program at Vienna's University Hospital – one of Europe's largest. He combines clinical expertise with academic leadership.

• Specializes in Non-Hodgkin's lymphoma diagnosis and treatment optimization
• Published 120+ scientific papers on hematologic oncology
• Board member of Austrian Society of Hematology and Oncology
• Trained at MD Anderson Cancer Center in Houston

Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic – specializing in blood disorder treatments with 36 years of experience of practice.

• Expert in Non-Hodgkin's lymphoma treatment
• Professor with extensive academic and clinical background
• Focuses on blood disorders at a leading hematology clinic

Dr. Alemdar specializes in Non-Hodgkin's lymphoma with extensive training in medical oncology at Akdeniz University.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at Akdeniz University Hospital, a leading institution in Turkey
• Member of the Turkish Medical Oncology Association

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.